Results 91 to 100 of about 6,270 (167)
Graves' hyperthyroidism and ophthalmopathy associated with pemphigus vulgaris
A 38-year-old caucasian woman developed typical Graves' hyperthyroidism and ophthalmopathy while being chronically treated for pemphigus vulgaris with low doses of glucocorticoids capable of effectively controlling skin disease, HLA typing showed ...
Bogazzi F. +4 more
core +1 more source
Prevalence of Graves ophthalmopathy among patients with thyroid disease
Objective: This study determined the prevalence of Graves ophthalmopathy among thyroid-disease patients at a tertiary government hospital. Methods: Patients with thyroid disease seen at a tertiary hospital from February to September 2007 were enrolled.
Erwin D. Palisoc, MD +2 more
doaj
UEG Week 2025 Poster Presentations
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley +1 more source
Inactive Graves' ophthalmopathy and self-esteem
PURPOSE: To assess the self-esteem of Graves' ophthalmopathy patients in the inactive phase. METHODS: Thirty euthyroid patients were evaluated in the inactive phase of disease with age ranging from 26 to 65 years, average of 43 ± 11,0 years, called study
Magalhães, Carlos Henrique de Toledo [UNIFESP] +5 more
core +1 more source
Typical graves\u27 ophthalmopathy in primary hypothyroidism
Graves ophthalmopathy (GO) usually occurs in a close temporal relationship with hyperthyroidism. It is rare in patients with normal thyroid function (euthyroid GO) and in patients with hypothyroid forms of thyroid autoimmune diseases (hypothyroid GO). We
Islam, Najmul +2 more
core +1 more source
Cigarette smoking and treatment outcomes in Graves' ophthalmopathy
Background: It is unclear whether smoking affects the course of Graves ophthalmopathy and therapeutic outcomes. Objective: To observe smoking behavior in a randomized study of the effect of radioiodine therapy on ophthalmopathy and in a case series of ...
Dell'Unto E. +8 more
core +1 more source
Steroid Treatment Focused Management of Graves’ Ophthalmopathy
Graves' disease (GD) is an autoimmune disease that affects the thyroid and the eyes. Graves' ophthalmopathy (GO), an autoimmune disease, usually appears 18 months after GD diagnosis.
Condeng Y. H. +5 more
doaj +1 more source
Evaluation of clinical features and risk factors in juvenile Graves' ophthalmopathy
[...]. Aim and objectives. The aim of the present study was to evaluate the features of juvenile Graves' ophthalmopathy and identify the risk factors that may influence the development of the disease. The objectives of the study were as follows: 1.
Jarušaitienė, Dalia
core
Antioxidant agents in the treatment of Graves' ophthalmopathy
PURPOSE: To report the effect of antioxidant agents in the treatment of mild and moderately severe Graves' ophthalmopathy. METHODS: Prospective, nonrandomized, comparative study performed at a referral center.
Bouzas, E.A. +3 more
core

